Waverley Pharmaceuticals

Canada’s Waverley Pharmaceuticals says it is stepping away from the generics market in order to concentrate entirely on novel drug development, after competitive pressures – including multiple rival

Canadian generic oncology specialist Waverley Pharmaceuticals has announced that it has cross-listed its stock on the Frankfurt Stock Exchange. Winnipeg-based Waverley was founded in 2014, and went

Tonix Looks To Prevent, Treat, Provide Precision Medicine In COVID-19 In the past month, Tonix Pharmaceuticals Holding Corp. has unveiled three separate partnerships to advance its efforts towards a

Small-molecule oncology generics specialist Waverley Pharmaceuticals has expanded its cancer portfolio in the UK by securing approval for a generic version of Roche’s Tarceva (erlotinib) oral treatm